AI assistant
Sending…
Lucid Diagnostics Inc. — Director's Dealing 2022
Jun 8, 2022
33983_dirs_2022-06-08_2d0f84e0-7e66-4609-b511-33bfb9dfb271.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-05-31
Reporting Person: Gordon Michael Adam (General Counsel)
More from Lucid Diagnostics Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 24
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 30
Capital/Financing Update
2026
Apr 23
Regulatory Filings
2026
Mar 27
Capital/Financing Update
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25